Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2014

Aug 28, 2014

30198_dirs_2014-08-28_12f6e5ec-7277-4861-9395-d17d330f54c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-08-26

Reporting Person: MOY JEFFREY (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-26 Common Stock M 10000.0 $9.8 Acquired 107916 Direct
2014-08-26 Common Stock S 10000.0 $45.5 Disposed 97916 Direct
2014-08-26 Common Stock M 6663.0 $6.33 Acquired 104579 Direct
2014-08-26 Common Stock S 6663.0 $45.0 Disposed 97916 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-26 Non-Qualified Stock Option (right to buy) $6.33 M 6663.0 Disposed 2018-09-24 Common Stock (6663) Direct
2014-08-26 Non-Qualified Stock Option (right to buy) $9.8 M 10000.0 Disposed 2020-03-12 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 146662 Indirect

Footnotes

F1: Included in this number are 97,916 unvested restricted stock units, 50,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 33,333 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 14,583 of which were granted on March 8, 2012 and shall vest through March 8, 2015.

F2: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.